Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Classifica tra le azioni #671
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Prezzo delle azioni
$18.87
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$36.24B
Variazione (1 giorno)
-0.11%
Variazione (1 anno)
26.14%
Paese
US
Scambia Kenvue Inc. (KVUE)

Categoria

Consumer Defensive
Storico del rendimento da dividendi per Kenvue Inc. (KVUE)
Il rendimento da dividendi (TTM) di Kenvue Inc. (simbolo azionario: KVUE) al 2023-12-31 è: 36.56%
Rendimento medio negli ultimi 5 anni: 8.08%
Storico del rendimento da dividendi per Kenvue Inc. (KVUE) da 2019 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
2026 (TTM) 5.79% 51.17%
2024 3.83% -89.52%
2023 36.56% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Rendimenti da dividendi (TTM) di aziende simili o concorrenti